Equal Management of Equal Risks: What Should be Used as the Standard for Cervical Cancer Prevention?
作者信息
Kinney Walter K, Perkins Rebecca B, Sawaya George F
机构信息
Global Coalition Against Cervical Cancer, Arlington, VA.
Department of Obstetrics and Gynecology, Boston Medical Center/Boston University School of Medicine, Boston, MA.
出版信息
J Low Genit Tract Dis. 2018 Jul;22(3):237-241. doi: 10.1097/LGT.0000000000000402.
Abstract
摘要
相似文献
1
Equal Management of Equal Risks: What Should be Used as the Standard for Cervical Cancer Prevention?同等风险的平等管理：宫颈癌预防应以何为标准？
J Low Genit Tract Dis. 2018 Jul;22(3):237-241. doi: 10.1097/LGT.0000000000000402.
2
Finding consensus on cervical cancer prevention.就宫颈癌预防达成共识。
Am J Public Health. 2012 Jun;102(6):1050-1; author reply 1051. doi: 10.2105/AJPH.2011.300539. Epub 2012 Apr 19.
3
Human papillomavirus vaccine inaccuracies.人乳头瘤病毒疫苗的不准确之处。
Am J Public Health. 2012 Mar;102(3):389-90; author reply 390. doi: 10.2105/AJPH.2011.300474. Epub 2012 Jan 19.
4
Prevention of cervical cancer in Central and Eastern Europe and Central Asia: a challenge for the future.中东欧和中亚地区宫颈癌的预防：未来的一项挑战。
Vaccine. 2013 Dec 31;31 Suppl 7:vii-ix. doi: 10.1016/j.vaccine.2012.11.105.
5
Towards cervical cancer eradication: joint force of HPV vaccination and HPV-based cervical cancer screening.迈向消除宫颈癌：HPV疫苗接种与基于HPV的宫颈癌筛查的联合力量
Clin Microbiol Infect. 2015 Sep;21(9):806-7. doi: 10.1016/j.cmi.2015.05.041. Epub 2015 Jun 9.
6
Developing role of HPV in cervical cancer prevention.人乳头瘤病毒（HPV）在宫颈癌预防中的发展作用。
BMJ. 2013 Aug 7;347:f4781. doi: 10.1136/bmj.f4781.
7
Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?宫颈癌预防的新进展：疗效、效果、消除？
PLoS Med. 2020 Jan 28;17(1):e1003035. doi: 10.1371/journal.pmed.1003035. eCollection 2020 Jan.
8
Screening for cervical cancer and human papillomavirus vaccination in Israel: recommendations.以色列宫颈癌筛查与人乳头瘤病毒疫苗接种：建议
Vaccine. 2013 Nov 22;31 Suppl 8:I58-60. doi: 10.1016/j.vaccine.2013.07.048.
9
Mapping new territory: emerging challenges in cervical cancer prevention.
Gynecol Oncol. 2014 Mar;132 Suppl 1:S1-2. doi: 10.1016/j.ygyno.2014.01.049.
10
Updates in Cervical Cancer Treatment.宫颈癌治疗的新进展。
Clin Obstet Gynecol. 2020 Mar;63(1):3-11. doi: 10.1097/GRF.0000000000000507.
引用本文的文献
1
A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.一种支持全球宫颈癌筛查和基于风险的管理的快速人乳头瘤病毒分型检测方法：一项横断面研究。
Int J Cancer. 2024 Jan 15;154(2):241-250. doi: 10.1002/ijc.34698. Epub 2023 Sep 29.
2
Development of a multivariable prediction model for anal high-grade squamous intraepithelial lesions in persons living with HIV in Puerto Rico: a cross-sectional study.波多黎各艾滋病毒感染者肛门高级别鳞状上皮内病变多变量预测模型的开发：一项横断面研究。
Lancet Reg Health Am. 2023 Jan;17. doi: 10.1016/j.lana.2022.100382. Epub 2022 Nov 4.
3
Human papillomavirus genotype-specific risks for cervical intraepithelial lesions.人乳头瘤病毒基因型特异性与宫颈上皮内病变风险。
Hum Vaccin Immunother. 2021 Apr 3;17(4):972-981. doi: 10.1080/21645515.2020.1814097. Epub 2020 Sep 29.
本文引用的文献
1
IPVS statement moving towards elimination of cervical cancer as a public health problem.IPVS声明：朝着消除宫颈癌这一公共卫生问题迈进。
Papillomavirus Res. 2018 Jun;5:87-88. doi: 10.1016/j.pvr.2018.02.003. Epub 2018 Feb 27.
2
Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 Years.21-39 岁女性宫颈上皮内瘤变 2 级（CIN2）保守治疗的临床结局。
Cancer Prev Res (Phila). 2018 Mar;11(3):165-170. doi: 10.1158/1940-6207.CAPR-17-0293. Epub 2018 Feb 5.
3
Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study.人乳头瘤病毒和细胞学联合检测若干阴性轮次对宫颈癌安全性的影响：一项观察性队列研究。
Ann Intern Med. 2018 Jan 2;168(1):20-29. doi: 10.7326/M17-1609. Epub 2017 Nov 28.
4
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.接种人乳头瘤病毒疫苗女性的最佳宫颈癌筛查
J Natl Cancer Inst. 2016 Oct 18;109(2). doi: 10.1093/jnci/djw216. Print 2017 Feb.
5
Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.美国宫颈癌筛查实践中的效率低下和高价值改进：成本效益分析。
Ann Intern Med. 2015 Oct 20;163(8):589-97. doi: 10.7326/M15-0420. Epub 2015 Sep 29.
6
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.p16/Ki-67双染细胞学检测HPV阳性女性的宫颈上皮内瘤变
J Natl Cancer Inst. 2015 Sep 15;107(12):djv257. doi: 10.1093/jnci/djv257. Print 2015 Dec.
7
Comparing Cervical Cytology and Histology Among Human Papillomavirus-Vaccinated and -Unvaccinated Women in an Academic Colposcopy Clinic.在一家学术性阴道镜诊所中，比较接种和未接种人乳头瘤病毒疫苗的女性的宫颈细胞学和组织学情况。
Obstet Gynecol. 2015 Oct;126(4):785-791. doi: 10.1097/AOG.0000000000001011.
8
Adverse psychological outcomes following colposcopy and related procedures: a systematic review.阴道镜检查及相关操作后的不良心理后果：系统评价。
BJOG. 2016 Jan;123(1):24-38. doi: 10.1111/1471-0528.13462. Epub 2015 Jun 22.
9
Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians.美国医师学院临床指南委员会关于普通风险女性的宫颈癌筛查：最佳实践建议。
Ann Intern Med. 2015 Jun 16;162(12):851-9. doi: 10.7326/M14-2426.
10
Identifying a "range of reasonable options" for cervical cancer screening.确定宫颈癌筛查的“一系列合理选项”。
Obstet Gynecol. 2015 Feb;125(2):308-310. doi: 10.1097/AOG.0000000000000670.
Zotero 插件